Webinar: Breast Cancer 2023 Data & Post-SABCS Summary
ctDNA in drug development for breast cancer Multiple studies have demonstrated that detection of molecular residual disease (MRD) is associated with poor prognosis in breast cancer. Ongoing prospectiv
